Insilico Medicine

Pharma

AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia

AZ pledged a $15 billion China investment. BI and Simcere inked a potential $1 billion IBD deal. Daiichi is navigating a complex ADC market. And more.

Angus Liu Jan 30, 2026 7:45am

Astellas, Takeda, Chugai and more—Fierce Pharma Asia

Jan 23, 2026 9:05am

China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia

Jan 9, 2026 3:00am

Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia

Dec 19, 2025 8:00am

Takeda, Sun, Ono—Fierce Pharma Asia

Mar 14, 2025 8:45am

Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia

Feb 14, 2025 9:51am